
Van Schaik
Articles
-
Nov 22, 2024 |
bmccancer.biomedcentral.com | Van Schaik |Van Harten |Lucas Frederik |Ellen Gurumay
In total, 19 stakeholders were interviewed from seven different regions in the Netherlands. The stakeholder group ‘molecular specialists’ consisted of three pathologists and four respondents who were either a molecular biologist in pathology or a laboratory specialist in clinical genetics (Table 2). The ‘medical specialists’ group consisted of four medical oncologists, one pulmonologist and two clinical geneticists.
-
Nov 19, 2024 |
academic.oup.com | location AMC |Van Schaik |van Royen-Kerkhof |van Wijk
Novel biomarkers are needed to guide therapy in idiopathic inflammatory myopathies (IIM). Expression of Siglec-1, a type I interferon biomarker, was examined in adult patients with IIM in relation to disease activity and treatment response. We analysed PBMC samples from 19 newly diagnosed adult IIM patients who participated in a phase-2 pilot study on efficacy of intravenous immunoglobulin (IVIG) monotherapy, and from 9 healthy controls.
-
Oct 31, 2024 |
arxiv.org | Van Schaik
-
Oct 29, 2024 |
arxiv.org | Ho Weng Hin |Van Schaik |Nazirah Mohd
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website. Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them. Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
-
Oct 18, 2024 |
mdpi.com | Markus Reuter |Van Schaik |Antoinette van Schaik
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →